Follow
Rodger Tiedemann
Rodger Tiedemann
Unknown affiliation
Verified email at uhn.ca
Title
Cited by
Cited by
Year
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
JJ Keats, R Fonseca, M Chesi, R Schop, A Baker, WJ Chng, S Van Wier, ...
Cancer cell 12 (2), 131-144, 2007
12102007
Genetic aberrations and survival in plasma cell leukemia
RE Tiedemann, N Gonzalez-Paz, RA Kyle, R Santana-Davila, ...
Leukemia 22 (5), 1044-1052, 2008
4432008
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
M Chesi, DF Robbiani, M Sebag, WJ Chng, M Affer, R Tiedemann, ...
Cancer cell 13 (2), 167-180, 2008
4382008
Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma
C Leung-Hagesteijn, N Erdmann, G Cheung, JJ Keats, AK Stewart, ...
Cancer cell 24 (3), 289-304, 2013
3972013
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
S Trudel, ZH Li, J Rauw, RE Tiedemann, XY Wen, AK Stewart
Blood, The Journal of the American Society of Hematology 109 (12), 5430-5438, 2007
2662007
Once-versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma
CB Reeder, DE Reece, V Kukreti, C Chen, S Trudel, K Laumann, J Hentz, ...
Blood, The Journal of the American Society of Hematology 115 (16), 3416-3417, 2010
2232010
Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II.
KR Hudson, RE Tiedemann, RG Urban, SC Lowe, JL Strominger, ...
The Journal of experimental medicine 182 (3), 711-720, 1995
2161995
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
JM Bogenberger, SM Kornblau, WE Pierceall, R Lena, D Chow, CX Shi, ...
Leukemia 28 (8), 1657-1665, 2014
2062014
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
J Schmidt, E Braggio, KM Kortuem, JB Egan, YX Zhu, CS Xin, ...
Leukemia 27 (12), 2357-2365, 2013
1702013
Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome
RE Tiedemann, YX Zhu, J Schmidt, CX Shi, C Sereduk, H Yin, S Mousses, ...
Cancer research 72 (3), 757-768, 2012
1452012
RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5
YX Zhu, R Tiedemann, CX Shi, H Yin, JE Schmidt, LA Bruins, JJ Keats, ...
Blood, The Journal of the American Society of Hematology 117 (14), 3847-3857, 2011
1312011
Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6
RE Tiedemann, YX Zhu, J Schmidt, H Yin, CX Shi, Q Que, G Basu, ...
Blood, The Journal of the American Society of Hematology 115 (8), 1594-1604, 2010
1192010
Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents
CI Chen, E Masih‐Khan, H Jiang, A Rabea, C Cserti‐Gazdewich, ...
British Journal of Haematology 162 (4), 483-488, 2013
1162013
Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
RE Tiedemann, JD Fraser
Journal of immunology (Baltimore, Md.: 1950) 157 (9), 3958-3966, 1996
1141996
Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-κB with antimyeloma activity in vitro and in vivo
RE Tiedemann, J Schmidt, JJ Keats, CX Shi, YX Zhu, SE Palmer, X Mao, ...
Blood, The Journal of the American Society of Hematology 113 (17), 4027-4037, 2009
1112009
The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action
PL Li, RE Tiedemann, SL Moffat, JD Fraser
The Journal of experimental medicine 186 (3), 375-383, 1997
1001997
Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity
RE Tiedemann, X Mao, CX Shi, YX Zhu, SE Palmer, M Sebag, R Marler, ...
The Journal of clinical investigation 118 (5), 1750-1764, 2008
882008
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin
X Mao, AK Stewart, R Hurren, A Datti, X Zhu, Y Zhu, C Shi, K Lee, ...
Blood, The Journal of the American Society of Hematology 110 (12), 4047-4054, 2007
642007
Patient-derived xenografts for prognostication and personalized treatment for head and neck squamous cell carcinoma
C Karamboulas, JP Bruce, AJ Hope, J Meens, SH Huang, N Erdmann, ...
Cell reports 25 (5), 1318-1331. e4, 2018
622018
Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure
R St Bernard, L Chodirker, E Masih-Khan, H Jiang, N Franke, V Kukreti, ...
Bone marrow transplantation 50 (1), 95-99, 2015
602015
The system can't perform the operation now. Try again later.
Articles 1–20